Citrullinated fibrin-filaggrin chimeric polypeptide capable...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/75 (2006.01) A61K 38/17 (2006.01) A61K 38/36 (2006.01) C07K 14/47 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2685756

The present invention concerns a chimeric polypeptide, capable of detecting the antibodies generated in rheumatoid arthritis, comprising at least two citrulinated peptide subunits: (i) one derived from the .alpha. or .beta. chain of the fibrin and (ii) a second derived from the filaggrin. In addition, the invention comprises an antigenic composition, a method and a kit for the diagnosis of rheumatoid arthritis, from the detection of the autoantibodies generated during the course of said disease.

La présente invention concerne un polypeptide recombiné, capable de détecter les anticorps générés dans la polyarthrite rhumatoïde, comprenant au moins deux sous-unités peptidiques citrullinées: (i) une provenant de la chaîne alpha ou bêta de la fibrine et (ii) une seconde provenant de la filagrine. L'invention concerne également une composition antigénique, une méthode et une trousse destinées au diagnostic de la polyarthrite rhumatoïde, par détection des auto-anticorps générés par cette maladie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Citrullinated fibrin-filaggrin chimeric polypeptide capable... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Citrullinated fibrin-filaggrin chimeric polypeptide capable..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Citrullinated fibrin-filaggrin chimeric polypeptide capable... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1766723

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.